Is severe deficiency of ADAMTS-13 specific for thrombotic thrombocytopenic purpura? Yes (Q28188189)

Journal of Thrombosis and Haemostasis

Europe PubMed Central

title

Is severe deficiency of ADAMTS-13 specific for thrombotic thrombocytopenic purpura? Yes (English)

0 references

1 reference

H-M Tsai

1

0 references

language of work or name

English

0 references

publication date

April 2003

0 references

published in

0 references

volume

1

0 references

issue

4

0 references

page(s)

625-31

0 references

cites work

Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1046/J.1538-7836.2003.00169.X

Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura

21 April 2017

1 reference

https://api.crossref.org/works/10.1046/J.1538-7836.2003.00169.X

Structure of von Willebrand factor-cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura

21 April 2017

1 reference

https://api.crossref.org/works/10.1046/J.1538-7836.2003.00169.X

Mutations and common polymorphisms in ADAMTS13 gene responsible for von Willebrand factor-cleaving protease activity

21 April 2017

1 reference

https://api.crossref.org/works/10.1046/J.1538-7836.2003.00169.X

Complement factor H and the haemolytic uraemic syndrome

21 April 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00169.X

Resistance development to fluoroquinolones in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00169.X

High titers of inhibitors of von Willebrand factor-cleaving metalloproteinase in a fatal case of acute thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00169.X

Immunohistochemistry of vascular lesion in thrombotic thrombocytopenic purpura, with special reference to factor VIII related antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00169.X

Increased von Willebrand factor binding to platelets in single episode and recurrent types of thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00169.X

von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00169.X

Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00169.X

Decreased von Willebrand factor protease activity associated with thrombocytopenic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00169.X

Specific von Willebrand factor-cleaving protease in thrombotic microangiopathies: a study of 111 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00169.X

von Willebrand factor cleaving protease (ADAMTS13) is deficient in recurrent and familial thrombotic thrombocytopenic purpura and hemolytic uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00169.X

A novel human metalloprotease synthesized in the liver and secreted into the blood: possibly, the von Willebrand factor-cleaving protease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00169.X

Cloning, expression, and functional characterization of the von Willebrand factor-cleaving protease (ADAMTS13).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00169.X

Remission of thrombotic thrombocytopenic purpura in a patient with compound heterozygous deficiency of von Willebrand factor-cleaving protease by infusion of solvent/detergent plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00169.X

Prothrombotic coagulation abnormalities preceding the hemolytic-uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00169.X

Antibody inhibitors to von Willebrand factor metalloproteinase and increased binding of von Willebrand factor to platelets in ticlopidine-associated thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00169.X

Von Willebrand factor-cleaving protease activity and proteolysis of von Willebrand factor in bone marrow transplant-associated thrombotic microangiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00169.X

Microangiopathic haemolytic anaemia in metastasizing malignant tumours is not associated with a severe deficiency of the von Willebrand factor-cleaving protease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00169.X

Changes in health and disease of the metalloprotease that cleaves von Willebrand factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00169.X

Von Willebrand factor-cleaving protease (ADAMTS13) in thrombocytopenic disorders: a severely deficient activity is specific for thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00169.X

Rituximab therapy for refractory thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00169.X